Research-stage water treatment solution that uses electrochemical reduction, UV-C LED photolysis, or a combination of both to destroy chloramine in water. Aimed at rapid, efficient chloramine removal for water treatment applications.
This research-stage technology explores the destruction of chloramine in water using electrochemical reduction, UV-C light from light emitting diodes (LEDs), or a combination of both approaches. Chloramine is a common disinfectant residual used in municipal water systems, but excess levels can cause taste, odor, and distribution system issues. The proposed solution targets rapid and efficient chloramine removal to desired levels, offering an alternative or complement to existing treatment methods.
The value proposition lies in combining two distinct destruction mechanisms to achieve faster and more complete chloramine removal than either technique alone. Electrochemical reduction leverages the oxidizable nature of chloramine, while UV-C LED photolysis exploits the known susceptibility of chloramine to deep-ultraviolet light. Together, these methods may enable compact, controllable treatment systems suitable for point-of-use or distribution-scale applications.
Core destruction mechanisms:
Planned development pathway:
This technology is at an early research stage. The research hypothesis has been formulated based on prior knowledge of chloramine electrochemistry and UV-C photolysis, but no validation procedures have been completed to date. Future validation will proceed from batch reactor experiments to flow reactor prototypes designed to meet targeted destruction levels at practical flow rates. The technology is not yet ready for commercial deployment and requires experimental confirmation of destruction kinetics and reactor performance before pilot or field testing.
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.